Gene expression leading to alterations in the DNA caused by asbestos exposure may explain the development of Malignant ...

DelveInsight Business Research LLP The malignant pleural mesothelioma market is poised for steady growth during the forecast period (2025–2034). The launch of innovative therapies by companies ...

The role of surgery for malignant pleural mesothelioma encompasses the need for rapid diagnosis, preoperative staging and surgical resection, and also the need for a greater biological ...

In the ATOMIC-Meso trial, arginine depletion therapy added to chemotherapy for mesothelioma improved survival, offering promising new hope for future treatments.

Keytruda plus chemotherapy is now a first-line treatment for pleural mesothelioma, replacing chemotherapy alone as the standard of care. The KEYNOTE-483 trial showed significant improvements in ...

What are some of the most common symptoms of mesothelioma? Pleural mesothelioma – a type of cancer caused by asbestos in the lining of the lungs – is the most common type of this disease.

Pleural mesothelioma (PM) is mainly caused by asbestos exposure and characterized by poor prognosis and limited therapeutic options. A recent research study led by Karin Schelch and Michael Grusch ...

Pleural mesothelioma starts in the layers of tissue that cover the lung (pleura). Surgery is not a common treatment for mesothelioma. Some people might have an operation to control and relieve ...